Eledon Pharmaceuticals, Inc. (ELDN) Operating income 2016–2023
Eledon Pharmaceuticals, Inc. (ELDN) annual operating income history from SEC filings — each fiscal year as reported.
-$43.0MFY2023 · since FY2016: -$5.1M → -$43.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$43.0M | +51.4% |
| FY2022 | -$88.4M | -139.9% |
| FY2021 | -$36.9M | -99.7% |
| FY2020 | -$18.5M | -15.0% |
| FY2019 | -$16.1M | -14.2% |
| FY2018 | -$14.1M | -7.2% |
| FY2017 | -$13.1M | -155.9% |
| FY2016 | -$5.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice